TIAA CREF Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $9.37M | Sell |
119,464
-732
| -0.6% | -$57.4K | 0.01% | 1071 |
|
|
2018
Q4 | $10.2M | Sell |
120,196
-1,959
| -2% | -$166K | 0.01% | 948 |
|
|
2018
Q3 | $20.9M | Sell |
122,155
-6,168
| -5% | -$1.06M | 0.01% | 719 |
|
|
2018
Q2 | $16.6M | Buy |
128,323
+10,318
| +9% | +$1.33M | 0.01% | 847 |
|
|
2018
Q1 | $12.2M | Buy |
118,005
+27,940
| +31% | +$2.88M | 0.01% | 1007 |
|
|
2017
Q4 | $7.69M | Sell |
90,065
-5,889
| -6% | -$503K | 0.01% | 1313 |
|
|
2017
Q3 | $8.15M | Sell |
95,954
-1,659
| -2% | -$141K | 0.01% | 1283 |
|
|
2017
Q2 | $7.39M | Buy |
97,613
+6,902
| +8% | +$523K | 0.01% | 1323 |
|
|
2017
Q1 | $5.99M | Sell |
90,711
-5,809
| -6% | -$384K | ﹤0.01% | 1477 |
|
|
2016
Q4 | $6.12M | Sell |
96,520
-125,290
| -56% | -$7.94M | ﹤0.01% | 1471 |
|
|
2016
Q3 | $14.1K | Buy |
221,810
+44,228
| +25% | +$2.82K | 0.01% | 930 |
|
|
2016
Q2 | $13.2M | Buy |
177,582
+3,063
| +2% | +$228K | 0.01% | 911 |
|
|
2016
Q1 | $11.7M | Buy |
174,519
+73,070
| +72% | +$4.88M | 0.01% | 973 |
|
|
2015
Q4 | $6.86M | Sell |
101,449
-2,817
| -3% | -$191K | 0.01% | 1318 |
|
|
2015
Q3 | $5.57M | Sell |
104,266
-12,261
| -11% | -$655K | ﹤0.01% | 1465 |
|
|
2015
Q2 | $7.34M | Sell |
116,527
-8,239
| -7% | -$519K | 0.01% | 1380 |
|
|
2015
Q1 | $6M | Sell |
124,766
-3,322
| -3% | -$160K | ﹤0.01% | 1498 |
|
|
2014
Q4 | $4.25M | Sell |
128,088
-9,028
| -7% | -$300K | ﹤0.01% | 1738 |
|
|
2014
Q3 | $4.02M | Sell |
137,116
-208,938
| -60% | -$6.12M | ﹤0.01% | 1769 |
|
|
2014
Q2 | $13.4M | Buy |
346,054
+56,937
| +20% | +$2.21M | 0.01% | 974 |
|
|
2014
Q1 | $12.1M | Buy |
289,117
+54,673
| +23% | +$2.29M | 0.01% | 1017 |
|
|
2013
Q4 | $7.69M | Buy |
234,444
+118,491
| +102% | +$3.89M | 0.01% | 1328 |
|
|
2013
Q3 | $3.13M | Sell |
115,953
-4,549
| -4% | -$123K | ﹤0.01% | 1922 |
|
|
2013
Q2 | $2.81M | Buy |
+120,502
| New | +$2.81M | ﹤0.01% | 1944 |
|